685 related articles for article (PubMed ID: 29349703)
1. Matrix Stiffness: the Conductor of Organ Fibrosis.
Santos A; Lagares D
Curr Rheumatol Rep; 2018 Jan; 20(1):2. PubMed ID: 29349703
[TBL] [Abstract][Full Text] [Related]
2. Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis.
Ruzehaji N; Frantz C; Ponsoye M; Avouac J; Pezet S; Guilbert T; Luccarini JM; Broqua P; Junien JL; Allanore Y
Ann Rheum Dis; 2016 Dec; 75(12):2175-2183. PubMed ID: 26961294
[TBL] [Abstract][Full Text] [Related]
3. Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma.
Tschumperlin DJ; Lagares D
Pharmacol Ther; 2020 Aug; 212():107575. PubMed ID: 32437826
[TBL] [Abstract][Full Text] [Related]
4. The Roles of Matrix Stiffness and ß-Catenin Signaling in Endothelial-to-Mesenchymal Transition of Aortic Valve Endothelial Cells.
Zhong A; Mirzaei Z; Simmons CA
Cardiovasc Eng Technol; 2018 Jun; 9(2):158-167. PubMed ID: 29761409
[TBL] [Abstract][Full Text] [Related]
5. Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis.
Lagares D; Santos A; Grasberger PE; Liu F; Probst CK; Rahimi RA; Sakai N; Kuehl T; Ryan J; Bhola P; Montero J; Kapoor M; Baron M; Varelas X; Tschumperlin DJ; Letai A; Tager AM
Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237758
[TBL] [Abstract][Full Text] [Related]
6. Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.
Hinz B; Lagares D
Nat Rev Rheumatol; 2020 Jan; 16(1):11-31. PubMed ID: 31792399
[TBL] [Abstract][Full Text] [Related]
7. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
[TBL] [Abstract][Full Text] [Related]
8. AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity.
Luo T; Nocon A; Fry J; Sherban A; Rui X; Jiang B; Xu XJ; Han J; Yan Y; Yang Q; Li Q; Zang M
Diabetes; 2016 Aug; 65(8):2295-310. PubMed ID: 27207538
[TBL] [Abstract][Full Text] [Related]
9. Mechanical aspects of lung fibrosis: a spotlight on the myofibroblast.
Hinz B
Proc Am Thorac Soc; 2012 Jul; 9(3):137-47. PubMed ID: 22802288
[TBL] [Abstract][Full Text] [Related]
10. Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-κβ signaling: Connecting fibrosis and inflammation.
Bale S; Pulivendala G; Godugu C
Biofactors; 2018 Nov; 44(6):507-517. PubMed ID: 30367690
[TBL] [Abstract][Full Text] [Related]
11. Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis.
Ragazzini S; Scocozza F; Bernava G; Auricchio F; Colombo GI; Barbuto M; Conti M; Pesce M; Garoffolo G
Acta Biomater; 2022 Oct; 152():300-312. PubMed ID: 36055606
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan's Role in Fibrosis: A Pathogenic Factor or a Passive Player?
Albeiroti S; Soroosh A; de la Motte CA
Biomed Res Int; 2015; 2015():790203. PubMed ID: 26583132
[TBL] [Abstract][Full Text] [Related]
13. The myofibroblast matrix: implications for tissue repair and fibrosis.
Klingberg F; Hinz B; White ES
J Pathol; 2013 Jan; 229(2):298-309. PubMed ID: 22996908
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanism Responsible for Fibronectin-controlled Alterations in Matrix Stiffness in Advanced Chronic Liver Fibrogenesis.
Iwasaki A; Sakai K; Moriya K; Sasaki T; Keene DR; Akhtar R; Miyazono T; Yasumura S; Watanabe M; Morishita S; Sakai T
J Biol Chem; 2016 Jan; 291(1):72-88. PubMed ID: 26553870
[TBL] [Abstract][Full Text] [Related]
15. [Transforming growth factor-beta and its receptors in scleroderma].
QIAN H; ZHENG M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
[TBL] [Abstract][Full Text] [Related]
16. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix.
Wipff PJ; Rifkin DB; Meister JJ; Hinz B
J Cell Biol; 2007 Dec; 179(6):1311-23. PubMed ID: 18086923
[TBL] [Abstract][Full Text] [Related]
17. The hard problem: Mechanotransduction perpetuates the myofibroblast phenotype in scleroderma fibrosis.
Leask A
Wound Repair Regen; 2021 Jul; 29(4):582-587. PubMed ID: 33410577
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
[TBL] [Abstract][Full Text] [Related]
19. Insights into myofibroblasts and their activation in scleroderma: opportunities for therapy?
Gyftaki-Venieri DA; Abraham DJ; Ponticos M
Curr Opin Rheumatol; 2018 Nov; 30(6):581-587. PubMed ID: 30074511
[TBL] [Abstract][Full Text] [Related]
20. Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis.
Ahamed J; Laurence J
Antioxid Redox Signal; 2017 Nov; 27(13):977-988. PubMed ID: 28562065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
